Masatoshi Eto
Impact in
-
- Renal cell carcinoma treatment
- Prostate Cancer Treatment and Research
- Immunology top 2%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
Papers in
-
- Prostate Cancer Treatment and Research 100
- Renal cell carcinoma treatment 88
- Prostate Cancer Diagnosis and Treatment 60
-
- Cancer Genomics and Diagnostics 29
- Co-authors
- Masaki ShiotaSeiji NaitoJunichi InokuchiArio TakeuchiKatsunori TatsugamiAkira YokomizoYasunobu YoshikaiEiji Kashiwagi
- Journals
- International Journal of Urology (47 papers)Journal of Clinical Oncology (28 papers)Cancer Science (18 papers)Japanese Journal of Clinical Oncology (15 papers)The Journal of Immunology (12 papers)
- Partner nations
- JapanUnited StatesItaly
In The Last Decade
Masatoshi Eto
371 papers receiving 5.7k citations
Peers
Comparison fields: 5 of 142
- Pulmonary and Respiratory Medicine 2.2k
- Immunology 1.4k
- Oncology 1.7k
- Cancer Research 885
- Hematology 465
Countries citing papers authored by Masatoshi Eto
This map shows the geographic impact of Masatoshi Eto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masatoshi Eto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masatoshi Eto more than expected).
Fields of papers citing papers by Masatoshi Eto
This network shows the impact of papers produced by Masatoshi Eto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masatoshi Eto. The network helps show where Masatoshi Eto may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Masatoshi Eto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 7 | |
| 7 | 2024 | 2 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 4 | |
| 10 | 2023 | 0 | |
| 11 | 2022 | 2 | |
| 12 | 2022 | 23 | |
| 13 | 2021 | 4 | |
| 14 | 2021 | 3 | |
| 15 | 2021 | 8 | |
| 16 | 2020 | 24 | |
| 17 | 2019 | 69 | |
| 18 | 2015 | 49 | |
| 19 | 2013 | 84 | |
| 20 | 2010 | 17 |
About Masatoshi Eto
Masatoshi Eto is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Oncology, Urology and Immunology, having authored 389 papers that have together received 5.8k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (100 papers), Renal cell carcinoma treatment (88 papers), Bladder and Urothelial Cancer Treatments (70 papers), Prostate Cancer Diagnosis and Treatment (60 papers), Cancer Immunotherapy and Biomarkers (49 papers), Renal and related cancers (41 papers), Immunotherapy and Immune Responses (36 papers) and Cancer Genomics and Diagnostics (29 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (2.2k citations), Immunology (1.4k citations), Oncology (1.7k citations), Cancer Research (885 citations) and Hematology (465 citations). Masatoshi Eto has collaborated with scholars based in Japan, United States and Italy. Frequent co-authors include Masaki Shiota, Seiji Naito, Junichi Inokuchi, Ario Takeuchi, Katsunori Tatsugami, Akira Yokomizo, Yasunobu Yoshikai, Eiji Kashiwagi, Hisanori Mayumi and Takeshi Uchiumi. Their work appears in journals such as International Journal of Urology, Journal of Clinical Oncology, Cancer Science, Japanese Journal of Clinical Oncology and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.